Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Galeazzi

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
Pharmacological Research|November 8, 2017
Transitioning from first- to second-generation biosimilars: An appraisal of regulatory and post-marketing challengesCorrado Blandizzi, Mauro Galeazzi, Guido Valesini
Autoimmunity Reviews|July 20, 2019
Antiphospholipid syndrome's genetic and epigenetic aspectsAnnamaria Iuliano, Mauro Galeazzi, Gian Domenico Sebastiani
The Israel Medical Association Journal : IMAJ|May 28, 2016
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?Estrella Garcia-Gonzalez, Mauro Galeazzi, Enrico Selvi
Autoimmunity Reviews|June 10, 2019
Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancerGian Domenico Sebastiani, Chiara Scirocco, Mauro Galeazzi
Autoimmunity Reviews|October 11, 2003
HLA class II alleles and genetic predisposition to the antiphospholipid syndromeGian Domenico Sebastiani, Giovanni Minisola, Mauro Galeazzi
Environmental Health Perspectives|August 13, 2009
Linking environmental particulate matter with genetic alterationsFrancesco Cetta, Armand Dhamo, Giuliana Malagnino, et al.
Clinical Rheumatology|April 1, 2005
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulinFrancesca Bellisai, Gabriella Morozzi, Roberto Marcolongo, et al.
Clinical Rheumatology|December 5, 2006
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infectionFrancesca Bellisai, Chiara Giannitti, Alessandro Donvito, et al.
Expert Opinion on Pharmacotherapy|March 17, 2009
Treatment strategies for a patient with rheumatoid arthritis and hepatitis CChiara Giannitti, Francesca Bellisai, Clodoveo Ferri, et al.
Rheumatology International|February 10, 2009
Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot studyAntonella Fioravanti, Marta Fabbroni, Alfonso Cerase, et al.
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Pharmacological Research|November 8, 2017
Transitioning from first- to second-generation biosimilars: An appraisal of regulatory and post-marketing challengesCorrado Blandizzi, Mauro Galeazzi, Guido Valesini
Autoimmunity Reviews|July 20, 2019
Antiphospholipid syndrome's genetic and epigenetic aspectsAnnamaria Iuliano, Mauro Galeazzi, Gian Domenico Sebastiani
The Israel Medical Association Journal : IMAJ|May 28, 2016
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?Estrella Garcia-Gonzalez, Mauro Galeazzi, Enrico Selvi
Autoimmunity Reviews|June 10, 2019
Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancerGian Domenico Sebastiani, Chiara Scirocco, Mauro Galeazzi
Autoimmunity Reviews|October 11, 2003
HLA class II alleles and genetic predisposition to the antiphospholipid syndromeGian Domenico Sebastiani, Giovanni Minisola, Mauro Galeazzi
Environmental Health Perspectives|August 13, 2009
Linking environmental particulate matter with genetic alterationsFrancesco Cetta, Armand Dhamo, Giuliana Malagnino, et al.
Clinical Rheumatology|April 1, 2005
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulinFrancesca Bellisai, Gabriella Morozzi, Roberto Marcolongo, et al.
Clinical Rheumatology|December 5, 2006
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infectionFrancesca Bellisai, Chiara Giannitti, Alessandro Donvito, et al.
Expert Opinion on Pharmacotherapy|March 17, 2009
Treatment strategies for a patient with rheumatoid arthritis and hepatitis CChiara Giannitti, Francesca Bellisai, Clodoveo Ferri, et al.
Rheumatology International|February 10, 2009
Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot studyAntonella Fioravanti, Marta Fabbroni, Alfonso Cerase, et al.
Pageof 27